Literature DB >> 10232418

Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis.

T K Lim1, N K Chin.   

Abstract

The efficacy of three different treatment protocols was compared: 1) simple chest tube drainage (Drain); 2) adjunctive intrapleural streptokinase (IP-SK); and 3) an aggressive empirical approach incorporating SK and early surgical drainage (SK+early OP) in patients with pleural empyema and high-risk parapneumonic effusions. This was a nonrandomized, prospective, controlled time series study of 82 consecutive patients with community-acquired empyema (n=68) and high-risk parapneumonic effusions (n=14). The following three treatment protocols were administered in sequence over 6 years: 1) Drain (n=29, chest catheter drainage); 2) IP-SK (n=23, adjunctive intrapleural fibrinolysis with 250,000 U x day(-1) SK); and 3) SK+early OP (n=30, early surgical drainage was offered to patients who failed to respond promptly following initial drainage plus SK). The average duration of hospital stay in the SK+early OP group was significantly shorter than in the Drain and IP-SK groups. The mortality rate was also significantly lower in the SK+early OP than the Drain groups (3 versus 24%). It was concluded that an empirical treatment strategy which combines adjunctive intrapleural fibrinolysis with early surgical intervention results in shorter hospital stays and may reduce mortality in patients with pleural sepsis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232418     DOI: 10.1183/09031936.99.13351499

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

1.  Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score.

Authors:  Sunkaru Touray; Rahul N Sood; Daniel Lindstrom; Jonathan Holdorf; Sumera Ahmad; Daniel B Knox; Andres F Sosa
Journal:  Lung       Date:  2018-08-11       Impact factor: 2.584

2.  Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.

Authors:  Emile S Altmann; Iain Crossingham; Stephen Wilson; Huw R Davies
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

3.  Intrapleural therapy in management of complicated parapneumonic effusions and empyema.

Authors:  Alaeldin H Ahmed; Tariq E Yacoub
Journal:  Clin Pharmacol       Date:  2010-11-22

4.  Role of medical thoracoscopy in the treatment of complicated parapneumonic effusions.

Authors:  Ramanjaneya Ranganatha; Syed Zulkharnain Tousheed; Bangalore Venkatraman MuraliMohan; Muhammed Zuhaib; Deepika Manivannan; B R Harish; Poojaramuddanahally Hanumantharayappa Manjunath; Kedar R Hibare; Hemanth Kumar; Chandrasekar Sagar; Vellaichamy Muthupandi Annapandian
Journal:  Lung India       Date:  2021 Mar-Apr

5.  Retrospective case-control study on the outcomes of early minimally invasive pleural lavage for pleural empyema in oncology patients.

Authors:  Paolo Nicola Camillo Girotti; Peter Tschann; Paolo Di Stefano; Martin Möschel; Nikolaus Hübl; Ingmar Königsrainer
Journal:  Thorac Cancer       Date:  2021-08-17       Impact factor: 3.500

6.  Plasmin improves blood-gas barrier function in oedematous lungs by cleaving epithelial sodium channels.

Authors:  Runzhen Zhao; Gibran Ali; Hong-Guang Nie; Yongchang Chang; Deepa Bhattarai; Xuefeng Su; Xiaoli Zhao; Michael A Matthay; Hong-Long Ji
Journal:  Br J Pharmacol       Date:  2020-05-11       Impact factor: 9.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.